See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348911_2019_Kalvista_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001348911, Kalvista Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 59,380,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,836,000 |
| 3 | remainder_Assets | 173,000 |
| 4 | LiabilitiesCurrent | 23,216,000 |
| 5 | LiabilitiesNoncurrent | 10,920,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,641,760 |
| 9 | ResearchAndDevelopmentExpense | 17,628,415 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 42,832,700 |
| 12 | remainder_NetIncome | 3,184,569 |
| 13 | remainder_ComprehensiveNetIncome | 1,097,226 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 61,389,000 |
| 1 | Liabilities | 34,136,000 |
| 2 | Expenses | 27,270,175 |
| 3 | Revenues | 42,832,700 |
| 4 | StockholdersEquity | 27,253,000 |
| 5 | NetIncome | 18,747,094 |
| 6 | ComprehensiveNetIncome | 19,295,707 |
| 7 | BaseVar | 84,954,835 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.65 |
| 9 | EconomicCapitalRatio | 2.78 |